Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience

Firas Baidoun, Dong Chen, Mrinal M Patnaik, Naseema Gangat, Kebede Begna, Michelle Elliott, William Hogan, Mark R Litzow, Aref Al-Kali

Research output: Contribution to journalArticle

Abstract

Myelodysplastic syndrome unclassifiable (MDS-U) is a small subtype of myelodysplastic syndromes (MDS). However, rare literature exists in terms of natural progression and clinical outcome of patients with MDS-U. In the present study, we investigated the characteristics and the clinical outcomes of patients categorized as MDS-U based on 2008 World Health Organization criteria (WHO) in a single center comparing to other MDS groups. Out of eight hundred and two patients who met WHO criteria for MDS at our institution, ninety patients (11%) were initially classified as MDS-U. Upon pathological review, only half of the cases were confirmed to be MDS-U. With follow up, half of the MDS-U cases were reclassified to another subtype. We found neither significant difference in median overall survival nor in risk of transformation to acute myeloid leukemia when comparing MDS-U to other MDS groups. Additional larger studies are needed to confirm our results.

Original languageEnglish (US)
JournalLeukemia and Lymphoma
DOIs
StatePublished - Jan 1 2019

Fingerprint

Myelodysplastic Syndromes
Acute Myeloid Leukemia

Keywords

  • Myelodysplastic syndrome
  • overall survival
  • unclassifiable
  • World Health Organization

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U) : single center experience. / Baidoun, Firas; Chen, Dong; Patnaik, Mrinal M; Gangat, Naseema; Begna, Kebede; Elliott, Michelle; Hogan, William; Litzow, Mark R; Al-Kali, Aref.

In: Leukemia and Lymphoma, 01.01.2019.

Research output: Contribution to journalArticle

@article{03402f15687642f6ae0be101583422fb,
title = "Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience",
abstract = "Myelodysplastic syndrome unclassifiable (MDS-U) is a small subtype of myelodysplastic syndromes (MDS). However, rare literature exists in terms of natural progression and clinical outcome of patients with MDS-U. In the present study, we investigated the characteristics and the clinical outcomes of patients categorized as MDS-U based on 2008 World Health Organization criteria (WHO) in a single center comparing to other MDS groups. Out of eight hundred and two patients who met WHO criteria for MDS at our institution, ninety patients (11{\%}) were initially classified as MDS-U. Upon pathological review, only half of the cases were confirmed to be MDS-U. With follow up, half of the MDS-U cases were reclassified to another subtype. We found neither significant difference in median overall survival nor in risk of transformation to acute myeloid leukemia when comparing MDS-U to other MDS groups. Additional larger studies are needed to confirm our results.",
keywords = "Myelodysplastic syndrome, overall survival, unclassifiable, World Health Organization",
author = "Firas Baidoun and Dong Chen and Patnaik, {Mrinal M} and Naseema Gangat and Kebede Begna and Michelle Elliott and William Hogan and Litzow, {Mark R} and Aref Al-Kali",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/10428194.2019.1581930",
language = "English (US)",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U)

T2 - single center experience

AU - Baidoun, Firas

AU - Chen, Dong

AU - Patnaik, Mrinal M

AU - Gangat, Naseema

AU - Begna, Kebede

AU - Elliott, Michelle

AU - Hogan, William

AU - Litzow, Mark R

AU - Al-Kali, Aref

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Myelodysplastic syndrome unclassifiable (MDS-U) is a small subtype of myelodysplastic syndromes (MDS). However, rare literature exists in terms of natural progression and clinical outcome of patients with MDS-U. In the present study, we investigated the characteristics and the clinical outcomes of patients categorized as MDS-U based on 2008 World Health Organization criteria (WHO) in a single center comparing to other MDS groups. Out of eight hundred and two patients who met WHO criteria for MDS at our institution, ninety patients (11%) were initially classified as MDS-U. Upon pathological review, only half of the cases were confirmed to be MDS-U. With follow up, half of the MDS-U cases were reclassified to another subtype. We found neither significant difference in median overall survival nor in risk of transformation to acute myeloid leukemia when comparing MDS-U to other MDS groups. Additional larger studies are needed to confirm our results.

AB - Myelodysplastic syndrome unclassifiable (MDS-U) is a small subtype of myelodysplastic syndromes (MDS). However, rare literature exists in terms of natural progression and clinical outcome of patients with MDS-U. In the present study, we investigated the characteristics and the clinical outcomes of patients categorized as MDS-U based on 2008 World Health Organization criteria (WHO) in a single center comparing to other MDS groups. Out of eight hundred and two patients who met WHO criteria for MDS at our institution, ninety patients (11%) were initially classified as MDS-U. Upon pathological review, only half of the cases were confirmed to be MDS-U. With follow up, half of the MDS-U cases were reclassified to another subtype. We found neither significant difference in median overall survival nor in risk of transformation to acute myeloid leukemia when comparing MDS-U to other MDS groups. Additional larger studies are needed to confirm our results.

KW - Myelodysplastic syndrome

KW - overall survival

KW - unclassifiable

KW - World Health Organization

UR - http://www.scopus.com/inward/record.url?scp=85062795191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062795191&partnerID=8YFLogxK

U2 - 10.1080/10428194.2019.1581930

DO - 10.1080/10428194.2019.1581930

M3 - Article

AN - SCOPUS:85062795191

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

ER -